Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −19,561−100.0% | Sold out | Holders |
| Q4 2023 | 19,561 | $287.9K | <0.1% | −13,469−40.8% | Reduced | Holders |
| Q3 2023 | 33,030 | $604.8K | <0.1% | −483−1.4% | Reduced | Holders |
| Q2 2023 | 33,513 | $722.9K | <0.1% | +33,513 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −19−100.0% | Sold out | Holders |
| Q2 2022 | 19 | $0 | 0.0% | +19 | New | Holders |